References
- Dahl O. Effects of hyperthermia on a neurogenic rat cell line (BT4A) in vivo. Acta Radiologica Oncology 1982; 21: 67–77
- Dahl O., Mella O. Enhanced effect of combined hyperthermia and chemotherapy (bleomycin, BCNU) in a neurogenic rat tumour (BT4A) in vivo. Anticancer Research 1982; 2: 359–364
- Edwards M. S., Levin V. A., Wilson C. B. Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trails. Cancer Treatment Reports 1980; 64: 1179–1205
- Field S. B., Anderson R. L. Thermotolerance: a review of observations and possible mechanisms. National Cancer Institute Monograph 1982; 61: 193–201
- Hahn G. M. Potential for therapy of drugs and hyperthermia. Cancer Research 1979; 39: 2264–2268
- Hahn G. M. Hyperthermia and Cancer. Plenum Press, New York and London 1982
- Hahn G. M. Thermotolerance and drugs. Mechanisms of Thermotolerance, K. Henle. CRC Press, Boca Raton, FL 1987; 97–112
- Hahn G. M., Strande D. P. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster ovary cells. Journal of the National Cancer Institute 1976; 57: 1063–1067
- Herman T. S., Sweets C. S., White D. M., Gerner E. W. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. Journal of the National Cancer Institute 1982; 68: 487–491
- Hochberg F. H., Pruitt A. A., Beck D. O., De Brun G., Davis K. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. Journal of Neurosurgery 1985; 63: 876–880
- Kamura T., Nielsen O. S., Overgaard J., Andersen A. H. Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo. Cancer Research 1982; 42: 1744–1748
- Laerum O. D., Rajewsky M. F., Schachner M., Stavrou D., Haglid K. G., Haugen A. Phenotypic properties of neoplastic cell lines developed from fetal rat brain cells in culture after exposure to ethylnitrosourea in vivo. Zeitschrift für Krebsforschung 1977; 89: 273–295
- Mella O. Hyperthermia or BCNU alone and combined in BD IX rats with BT4An tumours. Effects of a single or two equal fractions at different intervals. In Vivo 1988; 2: 307–312
- Mella O., Dahl O. Timing of combined hyperthermia and 1,3-(bis)2-chloroethyl)-l-nitrosourea or cis-diamminedichloroplatinurn in BD IX rats with BT4A tumours. Anticancer Research 1985; 5: 259–264
- Mann H. B., Whitney D. R. On a test of whether one of two random variables is stochastically larger than the other. Annals of Mathematics and Statistics 1947; 19: 50–60
- Morgan J. E., Honess D. J., Bleehen N. M. The interaction of thermal tolerance with drug cytotoxicity in vitro. British Journal of Cancer 1979; 39: 422–428
- Overgaard J., Nielsen O. S. The importance of thermotolerance for clinical treatment with hyperthermia. Radiotherapy and Oncology 1983; 1: 167–178
- Rofstad E. K., Brustad T. Development of thermotolerance in a human melanoma xenograft. Cancer Research 1984; 44: 525–530
- Roizin-Towle L., Pirro J. P. Thermotolerance in human cells of normal and neoplastic origin. International Journal of Hyperthermia 1988; 4: 665–675
- Urano M. Kinetics of thermotolerance in normal and tumor tissue: a review. Cancer Research 1986; 46: 474–482
- Urano M., Kahn B. S. Differential kinetics of thermal resistance (thermotolerance) between murine normal and tumor tissues. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 89–93
- Urano M., Rice L., Kahn J., Sedlacek R. S. Studies on fractionated hyperthermia in experimental animal systems. 1. The foot reaction after equal doses: heat resistance and repopulation. International Journal of Radiation Oncology, Biology, and Physics 1980; 6: 1519–1523
- Wheldon T. E., Hingston E. C., Ledda J. L. Hyperthermia response and thermotolerance capacity of an experimental rat tumour with occluded blood flow. European Journal of Cancer and Clinical Oncology 1982; 18: 1007–1015